Literature DB >> 21209468

Histoplasma capsulatum reactivation with haemophagocytic syndrome in a patient with chronic lymphocytic leukaemia.

M P van Koeveringe1, R E Brouwer.   

Abstract

We describe a case of haemophagocytic syndrome caused by Histoplasma capsulatum reactivation in a patient with chronic lymphocytic leukaemia treated with fludarabine and alemtuzumab. He presented with fever, pancytopenia, increased serum ferritin, lactate dehydrogenase and soluble interleukin-2 receptor. A bone marrow aspirate showed haemophagocytosis and possibly a yeast infection. Treatment with cyclosporine, dexamethasone, etoposide and caspofungin was started. After initial improvement his condition deteriorated. A second bone marrow examination confirmed a Histoplasma infection. After treatment with amphotericin B, the fever resolved and blood counts normalised. Haemophagocytic syndrome is a critical condition with high mortality that requires immunosuppressive therapy. The underlying cause should be investigated and treated. In this case a Histoplasma reactivation is described in a severely immunocompromised host years after the patient had left the endemic area.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21209468

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  13 in total

1.  Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in systemic lupus erythematosus.

Authors:  João Tadeu Damian Souto Filho; Priscilla Damião Araújo Lima; Alex Batista Paulo; Ana Luisa Silva Souza
Journal:  Int J Hematol       Date:  2017-08-07       Impact factor: 2.490

2.  Histoplasmosis on bone marrow aspirate cytological examination associated with hemophagocytosis and pancytopenia in an AIDS patient.

Authors:  Harish Chandra; Smita Chandra; Anita Sharma
Journal:  Korean J Hematol       Date:  2012-03-28

Review 3.  Transplantation in rare lymphoproliferative and histiocytic disorders.

Authors:  Alexis Cruz-Chacon; John Mathews; Ernesto Ayala
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

4.  Disseminated Histoplasmosis with Haemophagocytic Lymphohistiocytosis in an Immunocompetent Host.

Authors:  Amey Dilip Sonavane; Pratibha Balasaheb Sonawane; Sachet Vijay Chandak; Pravin M Rathi
Journal:  J Clin Diagn Res       Date:  2016-03-01

5.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

Review 6.  Reconstitution Inflammatory Syndrome Like Reactive Hemophagocytic Syndrome Associated with Disseminated Histoplasmosis in a HIV Patient.

Authors:  Sandra M Gómez-Espejo; Julián Olalla-Sierra; Pilar Marí-Jiménez; Teresa Pereda-Salguero; Javier Pérez-Stachowski; Javier de-la-Torre-Lima; Alfonso Del-Arco-Jiménez; José L Prada-Pardal
Journal:  Mycopathologia       Date:  2017-05-20       Impact factor: 2.574

7.  A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response.

Authors:  Adi Zoref-Lorenz; Mona Yuklea; Guy Topaz; Michael B Jordan; Martin Ellis
Journal:  J Gen Intern Med       Date:  2022-02-17       Impact factor: 6.473

8.  A case of hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia after treatment with fludarabine, cyclophosphamide, and rituximab chemotherapy, with autopsy findings.

Authors:  Ing S Tiong; Michael B Y Lau; Seventeen Toumoua; Shingirai Chiruka
Journal:  Case Rep Hematol       Date:  2012-12-17

9.  Histoplasmosis-Induced Hemophagocytic Syndrome: A Case Series and Review of the Literature.

Authors:  Jennifer Leigh Townsend; Satish Shanbhag; John Hancock; Kathryn Bowman; Ank E Nijhawan
Journal:  Open Forum Infect Dis       Date:  2015-04-15       Impact factor: 3.835

10.  Hemophagocytic Lymphohistiocytosis Secondary to Human Immunodeficiency Virus-Associated Histoplasmosis.

Authors:  Anthony A Castelli; David G Rosenthal; Rachel Bender Ignacio; Helen Y Chu
Journal:  Open Forum Infect Dis       Date:  2015-09-19       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.